Synthesis, development and preclinical comparison of two new peptide based freeze-dried kit formulation 99mTc-EDDA-Tricine-HYNIC-TOC and 99mTc-EDDA-Tricine-HYNIC-TATE for somatostatin receptor positive tumor scintigraphy

Daru

Volumn 14, Issue 4, 2006, Pages 183-189

  Gandomkar, M ^a   Najafi, R ^a   Babaei, M H ^a   Shafiei, M ^a   Sadat Ebrahimi, S E ^b  

^a ATOMIC ENERGY ORGANIZATION OF IRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

99mTc; HYNIC; Kit formulation; Somatostatin; Tyr 3 octreotate; Tyr3 octreotide

Indexed keywords

OCTREOTIDE; SOMATOSTATIN RECEPTOR; TECHNETIUM 99M;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONJUGATION; CONTROLLED STUDY; DRUG FORMULATION; EVALUATION; HYPOPHYSIS; ISOTOPE LABELING; KIDNEY FUNCTION; MALE; NONHUMAN; PANCREAS; RAT; SYNTHESIS; TUMOR SCINTISCANNING;

EID: 33846860276     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Arano Y, Akizawa H. Conventional and high-yield synthesis of DTPA-conjugated peptides: Application of a monoreactive DTPA to DTPA-d-Phe- octreotide synthesis. Bioconjug Chem 1997; 8: 442-446.
2. 99mTc: effect of different concentration of reducing agents and amount of sodium pertechnetate on radiolabelling efficiency. App Rad Iso 2003; 58: 361-364
3. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals. Chem Rev 1999; 99: 2235-2268
4. Abrams MJ, Juweid M, Tenkate CI, Schwartz DA, Hauser MM, Gaul FE, Fuccello AJ, Rubin RH, Strauss HW, Fischman AJ. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 1990; 31: 2022-2028
5. Atherton E, Sheppard R. Fluorenylmethoxycarbonyl-poly-amide solid phase peptide synthesis. General principles and development. Oxford : Oxford Information Press, 1989.
6. Wild D, Schmitt JS, Ginj M, Maecke HR, Bernard BF, Krenning E, Jong MD, Wenger S, Reubi JC. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labeling with various radiometals. Eur J Nucl Med Mol Imaging 2003; 30: 1338-47
7. Pierce K, Premont R, Lefkowitz R. Seven-transmembrane receptors. Nature Reviews. Mol Cell Biol 2002; 3: 639-50.
8. Drazin B, Sherman N, Sussman K, Dahl R, Vatter A. Internalization and cellular processing of somatostatin in primary culture of rat anterior pituitary cells. Endocrinology 1985; 117: 960-6.
9. Morel G, Pelletier G, Heisler S. Internalization and subcellular distribution of radiolabeled somatostatin-28 in mouse anterior pituitary tumor cells. Endocrinology 1986; 119: 1972-9.
10. Decristoforo C, Mather SJ. Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence. Eur J Nucl Med 1999; 26: 869-876.
11. Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt J, Maecke HR. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 2000; 27: 273-282
12. Mihaela G, Jianhua C, Walter MA, Eltschinger V, Reubi JC, Maecke HR. Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy. Clin Cancer Res 2005; 11: 1136-1145.
13. 8] Octreotide and [111In-DTPA0]Octreotide: Does tumor or pancreas uptake correlate with the rate of internalization?. J Nucl Med 2005; 46: 1561-1569.
14. Raulf F, Perez J, Hoyer D, Bruns C. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Digestion 1994; 55 Suppl 3: 46-53.